Marker Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell MRKR and other ETFs, options, and stocks.About MRKR
Marker Therapeutics, Inc. is a clinical-stage immuno-oncology company, which engages in the development and commercialization of novel cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company was founded on October 22, 1991 and is headquartered in Houston, TX.
MRKR Key Statistics
Stock Snapshot
The current Marker Therapeutics(MRKR) stock price is $1.62, with a market capitalization of 26.18M. The stock trades at a price-to-earnings (P/E) ratio of -1.75.
During the trading session on 2026-04-15, Marker Therapeutics(MRKR) shares reached a daily high of $1.75 and a low of $1.52. At a current price of $1.62, the stock is +6.6% higher than the low and still -7.4% under the high.
Trading volume for Marker Therapeutics(MRKR) stock has reached 181.58K, versus its average volume of 199.29K.
The stock's 52-week range extends from a low of $0.81 to a high of $4.07.
The stock's 52-week range extends from a low of $0.81 to a high of $4.07.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.